Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 455

Results For "EU"

4586 News Found

Altimmune expands AdCOVID manufacturing collaboration with Lonza
News | March 13, 2021

Altimmune expands AdCOVID manufacturing collaboration with Lonza

AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.


NATCO receives approval for Everolimus tablets for the US market
News | March 09, 2021

NATCO receives approval for Everolimus tablets for the US market

NATCO's partner BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks.


Vivimed Labs receives products approvals from Uzbekistan
News | March 09, 2021

Vivimed Labs receives products approvals from Uzbekistan

Vivimed strategy is to increase its share of Branded products in CIS Markets.


Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder
News | March 08, 2021

Glenmark signs on Rohit Sharma as brand ambassador of Candid Powder

Candid Powder brand is a market-leader in its category, with a market share of 64% in the medicated powder category.


Sun Pharma arm to acquire stake in WRS Bioproducts, Australia
News | March 06, 2021

Sun Pharma arm to acquire stake in WRS Bioproducts, Australia

The consideration to be paid will be AUD 2.0 mn for 12.5% stake.


Industry-academia collaboration key to strengthening pharma R&D
News | March 04, 2021

Industry-academia collaboration key to strengthening pharma R&D

The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .


Pharma sector will be $130 billion strong by 2030: EY-FICCI paper
News | March 04, 2021

Pharma sector will be $130 billion strong by 2030: EY-FICCI paper

The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades


Pharma 4.0: Pandemic pushed reluctant pharma companies to adopt advanced technologies
News | March 04, 2021

Pharma 4.0: Pandemic pushed reluctant pharma companies to adopt advanced technologies

Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.


Lupin launches penicillamine tablets USP
News | March 04, 2021

Lupin launches penicillamine tablets USP

Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).


DSM increases price for polyamide 6 and 66 in EMEA
News | March 02, 2021

DSM increases price for polyamide 6 and 66 in EMEA

The price increases are due to the rising costs of raw materials.